Literature DB >> 27708867

Familial Mediterranean fever: An updated review.

İsmail Sarı1, Merih Birlik1, Timuçin Kasifoğlu2.   

Abstract

Familial Mediterranean Fever (FMF) is a hereditary autoinflammatory disorder characterised by acute attacks of fever and serosal inflammation. FMF primarily affects Jewish, Armenian, Turkish, and Arab populations. The disease is accompanied by a marked decrease in quality of life due to the effects of attacks and subclinical inflammation in the attack-free periods. Untreated or inadequately treated patients run the risk of amyloidosis, which is an important cause of morbidity and mortality. In this review, the current information available on FMF is summarised.

Entities:  

Keywords:  Familial Mediterranean fever; aetiology; amyloidosis; review; treatment

Year:  2014        PMID: 27708867      PMCID: PMC5042258          DOI: 10.5152/eurjrheum.2014.006

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  167 in total

1.  Acute phase response and evolution of familial Mediterranean fever.

Authors:  M Tunca; G Kirkali; M Soytürk; S Akar; M B Pepys; P N Hawkins
Journal:  Lancet       Date:  1999-04-24       Impact factor: 79.321

2.  Necrotizing vasculitis associated with familial Mediterranean fever.

Authors:  Gulen Hatemi; Seval Masatlioglu; Feride Gogus; Huri Ozdogan
Journal:  Am J Med       Date:  2004-10-01       Impact factor: 4.965

Review 3.  Anti-TNF agents in familial Mediterranean fever: report of three cases and review of the literature.

Authors:  Salih Ozgocmen; Ozgur Akgul
Journal:  Mod Rheumatol       Date:  2011-05-13       Impact factor: 3.023

4.  Familial Mediterranean fever: an association with non-alcoholic fatty liver disease.

Authors:  Doron Rimar; Itzhak Rosner; Michael Rozenbaum; Eli Zuckerman
Journal:  Clin Rheumatol       Date:  2011-03-02       Impact factor: 2.980

5.  Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium.

Authors: 
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

6.  Prevalence of ischemic heart disease in patients with familial Mediterranean fever.

Authors:  P Langevitz; A Livneh; L Neumann; D Buskila; J Shemer; D Amolsky; M Pras
Journal:  Isr Med Assoc J       Date:  2001-01       Impact factor: 0.892

7.  Familial Mediterranean fever and central nervous system involvement: a case series.

Authors:  Umut Kalyoncu; Amber Eker; Kader K Oguz; Asli Kurne; Isilay Kalan; Akif M Topcuoglu; Banu Anlar; Yelda Bilginer; Mustafa Arici; Engin Yilmaz; Sedat Kiraz; Meral Calguneri; Rana Karabudak
Journal:  Medicine (Baltimore)       Date:  2010-03       Impact factor: 1.889

8.  The prevalence of familial Mediterranean fever in the Turkish province of Denizli: a field study with a zero patient design.

Authors:  V Cobankara; G Fidan; T Türk; M Zencir; M Colakoglu; S Ozen
Journal:  Clin Exp Rheumatol       Date:  2004 Jul-Aug       Impact factor: 4.473

9.  Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever.

Authors:  A Duzova; A Bakkaloglu; N Besbas; R Topaloglu; S Ozen; F Ozaltin; Y Bassoy; E Yilmaz
Journal:  Clin Exp Rheumatol       Date:  2003 Jul-Aug       Impact factor: 4.473

10.  Frequency of abdominal surgery in patients with familial Mediterranean fever.

Authors:  Timuçin Kaşifoğlu; Döndü Usküdar Cansu; Cengiz Korkmaz
Journal:  Intern Med       Date:  2009-04-01       Impact factor: 1.271

View more
  35 in total

1.  The importance of Mediterranean fever gene in familial Mediterranean fever.

Authors:  Demet Yalçın Kehribar; Metin Özgen
Journal:  Eur J Rheumatol       Date:  2020-07-21

2.  Risk factors for subclinical inflammation in children with Familial Mediterranean fever.

Authors:  Meral Torun Bayram; Tufan Çankaya; Elçin Bora; Salih Kavukçu; Ayfer Ülgenalp; Alper Soylu; Mehmet Türkmen
Journal:  Rheumatol Int       Date:  2015-02-11       Impact factor: 2.631

3.  Effect of interleukin-1 antagonists on the quality of life in familial Mediterranean fever patients.

Authors:  Ozkan Varan; Hamit Kucuk; Hakan Babaoglu; Nuh Atas; Reyhan Bilici Salman; Hasan Satis; Mehmet Akif Ozturk; Seminur Haznedaroglu; Berna Goker; Abdurrahman Tufan
Journal:  Clin Rheumatol       Date:  2018-12-10       Impact factor: 2.980

4.  Different pharmaceutical preparations of colchicine for Familial Mediterranean Fever: are they the same?

Authors:  Hakan Emmungil; Ufuk İlgen; Sezin Turan; Samet Yaman; Orhan Küçükşahin
Journal:  Rheumatol Int       Date:  2019-08-28       Impact factor: 2.631

Review 5.  Familial Mediterranean fever, review of the literature.

Authors:  Mansour Alghamdi
Journal:  Clin Rheumatol       Date:  2017-06-18       Impact factor: 2.980

6.  Relationship between endothelial dysfunction and microalbuminuria in familial Mediterranean fever.

Authors:  Hakan Güneş; Tarık Kıvrak; Mustafa Tatlısu; Hakkı Kaya; Mehmet Birhan Yılmaz
Journal:  Eur J Rheumatol       Date:  2016-04-05

7.  Neutrophil-lymphocyte ratio in children with familial Mediterranean fever: Original article.

Authors:  Fatma Duksal; Demet Alaygut; Ahmet Sami Güven; Mahmut Ekici; Mehmet Burhan Oflaz; Rukiye Tuncer; Ömer Cevit
Journal:  Eur J Rheumatol       Date:  2015-03-01

8.  Pattern and diagnostic evaluation of systemic autoinflammatory diseases other than familial Mediterranean fever among Arab children: a multicenter study from the Pediatric Rheumatology Arab Group (PRAG).

Authors:  Sulaiman M Al-Mayouf; Abdulaziz Almutairi; Safiya Albrawi; Basil M Fathalla; Raed Alzyoud; Abdullatif AlEnazi; Mohammed Abu-Shukair; Adel Alwahadneh; Abdullah Alsonbul; Mabruka Zlenti; Ebtisam Khawaja; Awatif Abushhaiwia; Khulood Khawaja; Zakiya AlMosawi; Wafa Madan; Muna Almuatiri; Nora Almuatiri
Journal:  Rheumatol Int       Date:  2019-11-18       Impact factor: 2.631

Review 9.  Amyloidoma: a review and case report.

Authors:  Sohil S Desai; Michael G Rizzo; Augustus J Rush; Andrew E Rosenberg; Motasem Al Maaieh
Journal:  Skeletal Radiol       Date:  2020-07-24       Impact factor: 2.199

10.  Canakinumab treatment in children with familial Mediterranean fever: report from a single center.

Authors:  Fatma Yazılıtaş; Özlem Aydoğ; Sare Gülfem Özlü; Evrim Kargın Çakıcı; Tülin Güngör; Fehime Kara Eroğlu; Gökçe Gür; Mehmet Bülbül
Journal:  Rheumatol Int       Date:  2018-02-15       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.